SCHEMBL8206500

SCHEMBL8206500

CNC(O)c1cc(=O)[nH]c2ccc(C)cc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.49
KDM4E B2RXH2 5/20 0.49
MAPT P10636 1/20 0.49
PKM P14618 1/20 0.49
KMT2A Q03164 4/20 0.42
MEN1 O00255 3/20 0.42
NPC1 O15118 2/20 0.42
POLB P06746 2/20 0.42
CA12 O43570 1/20 0.41
CA9 Q16790 1/20 0.41
LMNA P02545 4/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
HPGD P15428 3/20 0.40
MAPK1 P28482 1/20 0.40
RAB9A P51151 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MLKL Q8NB16 1/20 0.40
CHEK1 O14757 1/20 0.40
HSD17B10 Q99714 2/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15031157 0.83 ALDH1A1 (0.56) ALDH1A1KDM4EMAPTPKMKMT2A
SCHEMBL8211259 0.82 ALDH1A1 (0.51) ALDH1A1KDM4EMAPTPKMKMT2A
SCHEMBL10269991 0.82 HPGD (0.44) ALDH1A1KDM4ENPC1LMNASMN1; SMN2
SCHEMBL19690118 0.80 AR (0.56) ALDH1A1KDM4EMAPTPKMKMT2A
SCHEMBL8214258 0.79 ALDH1A1 (0.49) ALDH1A1KDM4EMAPTPKMKMT2A
SCHEMBL11458159 0.77 ALDH1A1 (0.56) ALDH1A1KDM4EMAPTPKMKMT2A
SCHEMBL9724162 0.73 LMNA (0.67) ALDH1A1KDM4EMAPTPKMKMT2A
SCHEMBL31475465 0.73 LMNA (0.67) ALDH1A1KDM4EMAPTPKMKMT2A
SCHEMBL2272868 0.73 ALDH1A1 (0.59) ALDH1A1KDM4EMAPTPKMKMT2A
SCHEMBL31081977 0.73 ALDH1A1 (0.59) ALDH1A1KDM4EMAPTPKMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1981854-B1 ARYLPROPIONAMIDE, ARYLACRYLAMIDE, ARYLPROPYNAMIDE, OR ARYLMETHYLUREA ANALOGS AS FACTOR XIA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2011-06-01 EP disclosed
WO-2008076805-A2 ARYLPROPIONAMIDE, ARYLACRYLAMIDE, ARYLPROPYNAMIDE, OR ARYLMETHYLUREA ANALOGS AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2008-06-26 WO disclosed
WO-2007070818-A1 SIX-MEMBERED HETEROCYCLES USEFUL AS SERINE PROTEASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-06-21 WO disclosed
WO-2007070816-A2 THIOPHENE DERIVATIVES AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-06-21 WO disclosed
WO-2007070826-A1 ARYLPROPIONAMIDE, ARYLACRYLAMIDE, ARYLPROPYNAMIDE, OR ARYLMETHYLUREA ANALOGS AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-06-21 WO disclosed